866-997-4948(US-Canada Toll Free)

United States Herpes Labialis Treatment Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 98 Pages

In this report, the United States Herpes Labialis Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Herpes Labialis Treatment in these regions, from 2013 to 2025 (forecast).

United States Herpes Labialis Treatment market competition by top manufacturers/players, with Herpes Labialis Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy's
Novartis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Acyclovir
Valacyclovir
Famciclovir
Penciclovir
Docosanol
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Topical
Oral

Table of Contents

United States Herpes Labialis Treatment Market Report 2018
1 Herpes Labialis Treatment Overview
1.1 Product Overview and Scope of Herpes Labialis Treatment
1.2 Classification of Herpes Labialis Treatment by Product Category
1.2.1 United States Herpes Labialis Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Herpes Labialis Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Acyclovir
1.2.4 Valacyclovir
1.2.5 Famciclovir
1.2.6 Penciclovir
1.2.7 Docosanol
1.3 United States Herpes Labialis Treatment Market by Application/End Users
1.3.1 United States Herpes Labialis Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Topical
1.3.3 Oral
1.4 United States Herpes Labialis Treatment Market by Region
1.4.1 United States Herpes Labialis Treatment Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Herpes Labialis Treatment Status and Prospect (2013-2025)
1.4.3 Southwest Herpes Labialis Treatment Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Herpes Labialis Treatment Status and Prospect (2013-2025)
1.4.5 New England Herpes Labialis Treatment Status and Prospect (2013-2025)
1.4.6 The South Herpes Labialis Treatment Status and Prospect (2013-2025)
1.4.7 The Midwest Herpes Labialis Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Herpes Labialis Treatment (2013-2025)
1.5.1 United States Herpes Labialis Treatment Sales and Growth Rate (2013-2025)
1.5.2 United States Herpes Labialis Treatment Revenue and Growth Rate (2013-2025)

2 United States Herpes Labialis Treatment Market Competition by Players/Suppliers
2.1 United States Herpes Labialis Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Herpes Labialis Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Herpes Labialis Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Herpes Labialis Treatment Market Competitive Situation and Trends
2.4.1 United States Herpes Labialis Treatment Market Concentration Rate
2.4.2 United States Herpes Labialis Treatment Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Herpes Labialis Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 United States Herpes Labialis Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Herpes Labialis Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Herpes Labialis Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Herpes Labialis Treatment Price by Region (2013-2018)

4 United States Herpes Labialis Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Herpes Labialis Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Herpes Labialis Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Herpes Labialis Treatment Price by Type (2013-2018)
4.4 United States Herpes Labialis Treatment Sales Growth Rate by Type (2013-2018)

5 United States Herpes Labialis Treatment Sales (Volume) by Application (2013-2018)
5.1 United States Herpes Labialis Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Herpes Labialis Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Herpes Labialis Treatment Players/Suppliers Profiles and Sales Data
6.1 Teva
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Herpes Labialis Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Teva Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Abbott
6.2.2 Herpes Labialis Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Abbott Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Sun
6.3.2 Herpes Labialis Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sun Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Mylan
6.4.2 Herpes Labialis Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Mylan Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Herpes Labialis Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
6.6.2 Herpes Labialis Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 GlaxoSmithKline Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Dr. Reddy's
6.7.2 Herpes Labialis Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Dr. Reddy's Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Novartis
6.8.2 Herpes Labialis Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis Herpes Labialis Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview

7 Herpes Labialis Treatment Manufacturing Cost Analysis
7.1 Herpes Labialis Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Herpes Labialis Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Herpes Labialis Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Herpes Labialis Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Herpes Labialis Treatment Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Herpes Labialis Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Herpes Labialis Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Herpes Labialis Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Herpes Labialis Treatment Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Herpes Labialis Treatment
Figure United States Herpes Labialis Treatment Market Size (K Units) by Type (2013-2025)
Figure United States Herpes Labialis Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Acyclovir Product Picture
Figure Valacyclovir Product Picture
Figure Famciclovir Product Picture
Figure Penciclovir Product Picture
Figure Docosanol Product Picture
Figure United States Herpes Labialis Treatment Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Herpes Labialis Treatment by Application in 2017
Figure Topical Examples
Table Key Downstream Customer in Topical
Figure Oral Examples
Table Key Downstream Customer in Oral
Figure United States Herpes Labialis Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Herpes Labialis Treatment Sales (K Units) and Growth Rate (2013-2025)
Figure United States Herpes Labialis Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Herpes Labialis Treatment Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Herpes Labialis Treatment Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Herpes Labialis Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Herpes Labialis Treatment Sales Share by Players/Suppliers
Figure 2017 United States Herpes Labialis Treatment Sales Share by Players/Suppliers
Figure United States Herpes Labialis Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Herpes Labialis Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Herpes Labialis Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Herpes Labialis Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Herpes Labialis Treatment Revenue Share by Players/Suppliers
Table United States Market Herpes Labialis Treatment Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Herpes Labialis Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Herpes Labialis Treatment Market Share of Top 3 Players/Suppliers
Figure United States Herpes Labialis Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Herpes Labialis Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Herpes Labialis Treatment Product Category
Table United States Herpes Labialis Treatment Sales (K Units) by Region (2013-2018)
Table United States Herpes Labialis Treatment Sales Share by Region (2013-2018)
Figure United States Herpes Labialis Treatment Sales Share by Region (2013-2018)
Figure United States Herpes Labialis Treatment Sales Market Share by Region in 2017
Table United States Herpes Labialis Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Herpes Labialis Treatment Revenue Share by Region (2013-2018)
Figure United States Herpes Labialis Treatment Revenue Market Share by Region (2013-2018)
Figure United States Herpes Labialis Treatment Revenue Market Share by Region in 2017
Table United States Herpes Labialis Treatment Price (USD/Unit) by Region (2013-2018)
Table United States Herpes Labialis Treatment Sales (K Units) by Type (2013-2018)
Table United States Herpes Labialis Treatment Sales Share by Type (2013-2018)
Figure United States Herpes Labialis Treatment Sales Share by Type (2013-2018)
Figure United States Herpes Labialis Treatment Sales Market Share by Type in 2017
Table United States Herpes Labialis Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Herpes Labialis Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Herpes Labialis Treatment by Type (2013-2018)
Figure Revenue Market Share of Herpes Labialis Treatment by Type in 2017
Table United States Herpes Labialis Treatment Price (USD/Unit) by Types (2013-2018)
Figure United States Herpes Labialis Treatment Sales Growth Rate by Type (2013-2018)
Table United States Herpes Labialis Treatment Sales (K Units) by Application (2013-2018)
Table United States Herpes Labialis Treatment Sales Market Share by Application (2013-2018)
Figure United States Herpes Labialis Treatment Sales Market Share by Application (2013-2018)
Figure United States Herpes Labialis Treatment Sales Market Share by Application in 2017
Table United States Herpes Labialis Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Herpes Labialis Treatment Sales Growth Rate by Application (2013-2018)
Table Teva Basic Information List
Table Teva Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Teva Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Teva Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Abbott Basic Information List
Table Abbott Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Abbott Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Abbott Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Sun Basic Information List
Table Sun Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sun Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Sun Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Sun Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Mylan Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Mylan Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Pfizer Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Pfizer Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Dr. Reddy's Basic Information List
Table Dr. Reddy's Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dr. Reddy's Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Dr. Reddy's Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Dr. Reddy's Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Herpes Labialis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Herpes Labialis Treatment Sales Growth Rate (2013-2018)
Figure Novartis Herpes Labialis Treatment Sales Market Share in United States (2013-2018)
Figure Novartis Herpes Labialis Treatment Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Herpes Labialis Treatment
Figure Manufacturing Process Analysis of Herpes Labialis Treatment
Figure Herpes Labialis Treatment Industrial Chain Analysis
Table Raw Materials Sources of Herpes Labialis Treatment Major Players/Suppliers in 2017
Table Major Buyers of Herpes Labialis Treatment
Table Distributors/Traders List
Figure United States Herpes Labialis Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Herpes Labialis Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Herpes Labialis Treatment Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Type in 2025
Table United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Application in 2025
Table United States Herpes Labialis Treatment Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Herpes Labialis Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Herpes Labialis Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Herpes Labialis Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *